Table 2.
365 day mortality | Heart failure event | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||||||
HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | |
Anaemia status on Day 3 | ||||||||||||
No‐AKI/no‐WRF | 1.000 | 1.000 | 1.000 | 1.000 | ||||||||
No‐AKI/WRF | 1.395 | 0.895−2.174 | 0.141 | 1.248 | 0.768–2.028 | 0.370 | 1.210 | 0.896–1.635 | 0.214 | 1.110 | 0.803–1.534 | 0.527 |
AKI/no‐WRF | 2.234 | 1.482–3.368 | <0.001 | 1.916 | 1.234–2.974 | 0.004 | 1.214 | 0.883–1.667 | 0.232 | 1.060 | 0.748–1.502 | 0.742 |
AKI/WRF | 5.942 | 4.025–8.771 | <0.001 | 3.622 | 2.332–5.624 | <0.001 | 3.288 | 2.431–4.446 | <0.001 | 2.424 | 1.718–3.419 | <0.001 |
Adjusted factors (data of Day 1) | ||||||||||||
Age (per 1 year increase) | 1.034 | 1.019–1.049 | <0.001 | 1.030 | 1.013–1.047 | <0.001 | 1.026 | 1.015–1.036 | <0.001 | 1.023 | 1.011–1.035 | <0.001 |
SBP (per 10 mmHg increase) | 0.857 | 0.827–0.889 | <0.001 | 0.889 | 0.852–0.928 | <0.001 | 0.931 | 0.906–0.957 | <0.001 | 0.960 | 0.930–0.992 | 0.014 |
LVEF (per 1% increase) | 0.999 | 0.991–1.008 | 0.895 | 0.993 | 0.987–1.000 | 0.063 | 0.989 | 0.981–0.996 | 0.003 | |||
Sodium (per 1.0 mmol/L increase) | 0.937 | 0.913–0.961 | <0.001 | 0.953 | 0.933–0.973 | <0.001 | 0.974 | 0.952–0.997 | 0.030 | |||
Haemoglobin (per 1.0 mg/dL increase) | 0.843 | 0.797–0.891 | <0.001 | 0.934 | 0.874–0.999 | 0.046 | 0.892 | 0.855–0.930 | <0.001 | 0.936 | 0.888–0.986 | 0.012 |
BNP (per 10 pg/mL increase) | 1.002 | 1.002–1.003 | <0.001 | 1.001 | 1.001–1.002 | 0.001 | 1.002 | 1.001–1.002 | <0.001 |
AKI; acute kidney injury; BNP, brain natriuretic peptide; CI, confidence interval; HR, hazard ratio; LVEF, left ventricular ejection fraction measured on echocardiography; SBP, systolic blood pressure; WRF; worsening renal function.